Lee's Pharmaceutical Holdings Limited (FRA:L1PA)
Germany
· Delayed Price · Currency is EUR 0.178
0.00 (0.00%)
At close: Dec 4, 2025
FRA:L1PA Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 109 | 104 | 104 | 115 | 221 | 291 | Upgrade
|
| Market Cap Growth | 19.32% | -0.34% | -9.41% | -47.91% | -24.14% | -1.96% | Upgrade
|
| Enterprise Value | 89 | 100 | 100 | 90 | 201 | 265 | Upgrade
|
| Last Close Price | 0.17 | 0.16 | 0.16 | 0.17 | 0.32 | - | Upgrade
|
| PE Ratio | 10.30 | 8.98 | 53.95 | 18.72 | 0.99 | 21.38 | Upgrade
|
| PS Ratio | 0.70 | 0.60 | 0.86 | 0.78 | 1.55 | 2.27 | Upgrade
|
| PB Ratio | 0.55 | 0.54 | 0.46 | 0.52 | 0.82 | 1.31 | Upgrade
|
| P/TBV Ratio | 1.45 | 0.63 | 0.51 | 0.59 | 0.91 | 1.49 | Upgrade
|
| P/FCF Ratio | 3.10 | 4.22 | 11.17 | 3.61 | 12.26 | 34.33 | Upgrade
|
| P/OCF Ratio | 2.74 | 3.46 | 8.18 | 3.38 | 9.31 | 12.63 | Upgrade
|
| EV/Sales Ratio | 0.56 | 0.57 | 0.82 | 0.61 | 1.41 | 2.07 | Upgrade
|
| EV/EBITDA Ratio | 3.48 | 3.64 | 6.62 | 3.15 | 105.94 | 9.64 | Upgrade
|
| EV/EBIT Ratio | 6.14 | 6.01 | 23.98 | 5.89 | - | 16.83 | Upgrade
|
| EV/FCF Ratio | 2.53 | 4.05 | 10.72 | 2.82 | 11.15 | 31.23 | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.15 | 0.10 | 0.09 | 0.11 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 1.04 | 0.98 | 1.42 | 0.65 | 8.39 | 0.57 | Upgrade
|
| Debt / FCF Ratio | 0.75 | 1.15 | 2.53 | 0.61 | 1.67 | 1.95 | Upgrade
|
| Asset Turnover | 0.52 | 0.51 | 0.37 | 0.38 | 0.37 | 0.35 | Upgrade
|
| Inventory Turnover | 2.64 | 2.21 | 1.83 | 1.59 | 1.23 | 1.30 | Upgrade
|
| Quick Ratio | 0.71 | 0.55 | 0.46 | 0.46 | 0.51 | 0.61 | Upgrade
|
| Current Ratio | 1.06 | 1.02 | 1.01 | 1.00 | 1.04 | 1.31 | Upgrade
|
| Return on Equity (ROE) | 3.73% | 3.91% | 1.05% | 2.17% | 86.98% | 3.42% | Upgrade
|
| Return on Assets (ROA) | 3.00% | 3.03% | 0.79% | 2.48% | -1.73% | 2.71% | Upgrade
|
| Return on Capital (ROIC) | 4.21% | 4.24% | 1.08% | 3.42% | -2.41% | 3.80% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.10% | 7.20% | 1.60% | 6.00% | -3.50% | 6.50% | Upgrade
|
| Earnings Yield | 9.71% | 11.13% | 1.85% | 5.34% | 101.34% | 4.68% | Upgrade
|
| FCF Yield | 32.27% | 23.69% | 8.95% | 27.73% | 8.16% | 2.91% | Upgrade
|
| Dividend Yield | 2.93% | 3.48% | 1.31% | 1.39% | 2.16% | - | Upgrade
|
| Payout Ratio | 27.09% | 18.97% | 63.48% | 47.08% | 1.81% | 29.56% | Upgrade
|
| Buyback Yield / Dilution | - | 0.00% | 0.00% | 0.04% | -0.15% | 0.63% | Upgrade
|
| Total Shareholder Return | 2.93% | 3.48% | 1.31% | 1.42% | 2.01% | 0.63% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.